THC Therapeutics, Inc.
THCT
$0.0001
-$0.0002-66.67%
OTC PK
| 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 379.70K | 85.20K | 55.20K | 54.70K | 58.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 379.70K | 85.20K | 55.20K | 54.70K | 58.00K |
| Operating Income | -379.70K | -85.20K | -55.20K | -54.70K | -58.00K |
| Income Before Tax | 104.60K | -572.00K | -62.50K | -32.90K | 94.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 104.60K | -572.00K | -62.50K | -32.90K | 94.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 104.60K | -572.00K | -62.50K | -32.90K | 94.40K |
| EBIT | -379.70K | -85.20K | -55.20K | -54.70K | -58.00K |
| EBITDA | -379.40K | -84.80K | -54.90K | -54.30K | -57.70K |
| EPS Basic | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.02 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 38.33M | 32.87M | 32.75M | 32.99M | 32.75M |
| Average Diluted Shares Outstanding | 38.33M | 32.87M | 32.75M | 32.99M | 32.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |